BlackRock Fund Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Fund Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$40.9M	Buy	380,241 +22,851	+6%	+$2.67M	0.01%	1809
2016 Q3	$44.5M	Buy	357,390 +16,680	+5%	+$1.97M	0.01%	1663
2016 Q2	$36.2M	Sell	340,710 -5,117	-1%	-$594K	0.01%	1702
2016 Q1	$39.6M	Buy	345,827 +40,098	+13%	+$4.7M	0.01%	1588
2015 Q4	$43.6M	Buy	+305,729	New	+$35.3M	0.01%	1567

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

BlackRock Fund Advisors's CBPO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its China Biologic Products Holdings, Inc. (CBPO) stake by 6.4% in Q4 2016, buying an estimated $2.67M and bringing the position to 380,241 shares worth $40.9M. The position accounts for 0.01% of the portfolio, ranked #1809.

BlackRock Fund Advisors first reported a position in CBPO in Q4 2015 and has held it in 5 quarters since. The position peaked at $44.5M in Q3 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

BlackRock Fund Advisors held 380,241 shares of China Biologic Products Holdings, Inc. worth $40.9M as of Q4 2016.
BlackRock Fund Advisors bought 22,851 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $2.67M.
China Biologic Products Holdings, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1809 holding.
BlackRock Fund Advisors first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's China Biologic Products Holdings, Inc. position peaked at $44.5M in Q3 2016.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.